Von Hippel-Lindau Syndrome
Also known as: Von-Hippel Lindau / Von Hippel Lindau / Hippel-Lindau Disease / Von Hippel-Lindau Disease / Von Hippel-Lindau syndrome (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB15463 | Belzutifan | An inhibitor of hypoxia-inducible factor 2α used as an antineoplastic in the treatment of certain cancers associated with von Hippel-Lindau (VHL) disease. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00112 | Bevacizumab | 0 | Terminated | 1 |
DB17969 | Edotreotide | 0 | Terminated | 1 |
DB15494 | Edotreotide gallium Ga-68 | 0 | Terminated | 1 |
DB04895 | Pegaptanib | 1 | Completed | 1 |
DB01270 | Ranibizumab | 1 | Completed | 1 |
DB02546 | Vorinostat | 1 | Completed | 1 |
DB06325 | Pegpleranib | 1 / 2 | Completed | 1 |
DB01270 | Ranibizumab | 1 / 2 | Completed | 2 |
DB01268 | Sunitinib | 1 / 2 | Terminated | 1 |
DB14099 | 1,2-Distearoyllecithin | 2 | Completed | 1 |
DB15463 | Belzutifan | 2 | Active Not Recruiting | 1 |
DB15463 | Belzutifan | 2 | Recruiting | 1 |
DB14554 | Dotatate | 2 | Completed | 1 |
DB14554 | Dotatate | 2 | Recruiting | 1 |
DB05928 | Dovitinib | 2 | Terminated | 1 |
DB14233 | Egg phospholipids | 2 | Completed | 1 |
DB15107 | Fludeoxyglucose | 2 | Completed | 1 |
DB09150 | Fludeoxyglucose (18F) | 2 | Completed | 1 |
DB16055 | PT-2385 | 2 | Completed | 1 |
DB06589 | Pazopanib | 2 | Completed | 1 |
DB00556 | Perflutren | 2 | Completed | 1 |
DB14105 | Sodium 1,2-Dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol) | 2 | Completed | 1 |
DB11104 | Sulfur hexafluoride | 2 | Completed | 1 |
DB01268 | Sunitinib | 2 | Completed | 1 |
DB01268 | Sunitinib | 2 | Terminated | 1 |
DB06398 | Tanespimycin | 2 | Completed | 1 |
DB05294 | Vandetanib | 2 | Completed | 1 |
DB04879 | Vatalanib | 2 | Completed | 1 |
DB00571 | Propranolol | Not Available | Recruiting | 1 |